Alerts will be sent to your verified email
Verify Email
LINCOLN
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Lincoln Pharmaceuticals Ltd specializes in producing and promoting cost-effective therapeutic products such as Tablets, Capsules, Injectables, Syrups, and Ointments.
Lincoln Pharma major competitors are Kwality Pharma, Bharat Parenterals, Wanbury, Anuh Pharma, Ind-Swift Lab., Sakar Healthcare, Shivalik Rasayan.
Market Cap of Lincoln Pharma is ₹1,086 Crs.
While the median market cap of its peers are ₹875 Crs.
Lincoln Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Jun Sep Dec | Sep | Dec | |||||||||||
| Investor Presentation | Mar | Mar Jun Sep Dec | Sep Dec | Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Mar Jun | Jun Dec | |||||||
| Conference Call | Mar | |||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
